Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S44121 versus placebo in catecholaminergic polymorphic ventricular tachycardia type 1
2011-000579-15Phase 2Terminated
- Sponsor
- Servier
- Start
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in catecholaminergic polymorphic ventricular tachycardia type 1 (CPVT1) comparing S44121 with Placebo (2 arms). Primary endpoint: Cardiac arrhythmias during standardised exercise tests. Started Oct 2011; status: terminated.
02
Drugs
S44121
03
Conditions
catecholaminergic polymorphic ventricular tachycardia type 1 (CPVT1)
Beyond the preview
Go deeper on 2011-000579-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000579-15.